VCF formatted files are the lingua franca of next-generation sequencing, whereas HL7 FHIR is rising as a commonplace language for digital well being document interoperability. A rising variety of FHIR-based scientific genomics functions are rising. Here, we describe an open supply utility for changing variants from VCF format into HL7 FHIR format. vcf2fhir converts VCF variants into a FHIR Genomics Diagnostic Report. Conversion interprets every VCF row into a corresponding FHIR-formatted variant within the generated report. In scope are easy variants (SNVs, MNVs, Indels), together with zygosity and section relationships, for autosomes, intercourse chromosomes, and mitochondrial DNA. Input parameters embody VCF file and genome construct (‘GRCh37’ or ‘GRCh38’); and optionally a conversion area that signifies the area(s) to convert, a studied area that lists genomic areas studied by the lab, and a non-callable area that lists studied areas deemed uncallable by the lab.
Conversion may be restricted to a subset of VCF by supplying genomic coordinates of the conversion area(s). If studied and non-callable areas are additionally provided, the output FHIR report will embody ‘region-studied’ observations that element which parts of the conversion area have been studied, and of these studied areas, which parts have been deemed uncallable. We illustrate the vcf2fhir utility by way of two case research. The first, ‘SMART Cancer Navigator’, is a net utility that provides scientific resolution assist by linking affected person EHR data to cancerous gene variants.
The second, ‘Precision Genomics Integration Platform’, intersects a affected person’s FHIR-formatted scientific and genomic information with information bases so as to present on-demand supply of contextually related genomic findings and proposals to the EHR. Experience to date exhibits that the vcf2fhir utility may be successfully woven into clinically helpful genomic-EHR integration pipelines. Additional testing can be a crucial step in the direction of the scientific validation of this utility, enabling it to be built-in in a number of actual world information movement situations. For now, we suggest using this utility primarily to speed up FHIR Genomics understanding and to facilitate experimentation with additional integration of genomics information into the EHR.
Implementation of Bio-Risk Management System in a National Clinical and Medical Referral Centre Laboratories
The rising threats from organic brokers have turn into a concern in laboratories, and rising infectious ailments have demanded elevated consciousness and preparedness of laboratory amenities. Bio-risk evaluation is required to present a framework for organisations to set up a complete bio-risk administration system. The evaluation standards ought to embody each biosafety and biosecurity measures. Laboratories in Indonesia play a important function in public well being interventions in time period of illness screening, analysis and medical resolution making. The National Clinical and Medical Referral Centre Laboratories have the potential of day by day exposures to harmful organic supplies.
This research goals to establish the hole between bio-risk administration system implementation and International Standard Organisation (ISO) 35001:2019 necessities. The 202 gadgets in ISO 35001:2019 are categorized into seven predominant components. The findings present that greater than half of the weather on ISO 35001:2019 have been applied in these centres. Good efficiency was recognized at lab Four and 5 which obtained the very best scores, notably within the context of organisation, planning, operation and enchancment components. However, the widest hole was present in management, assist and efficiency analysis. One means to deal with this could be to create written guidelines and laws on the laboratory high administration degree to require all laboratory amenities to comply to the bio-risk insurance policies, guidelines, and laws.
Out of the Lab and Into the Field: Validation of Portable Cell Culture Protocols
Field-based analysis on irritation and well being is usually restricted to baseline measures of circulating cytokines or acute section proteins, whereas lab-based research can pursue a extra dynamic strategy with ex vivo cell tradition strategies. The laboratory infrastructure required for culturing leukocytes limits utility in community-based settings, which in flip limits scientific understandings of how psychosocial, behavioral, and contextual components affect the regulation of irritation. We evaluated the efficiency of each protocols towards a commonplace laboratory-based protocol, utilizing matched venous and capillary blood samples collected from younger adults (N=24). Samples have been incubated with lipopolysaccharide (LPS) and hydrocortisone, and the manufacturing of pro-inflammatory cytokines IL-1β, IL-6 and TNFα was measured in response.
Anti-Mouse LIF Antibody |
103-M263 |
ReliaTech |
100 µg |
EUR 399 |
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Anti-Mouse LIF Antibody |
103-PA05S |
ReliaTech |
100 µg |
EUR 126 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
Mouse LIF Protein |
E40MOP1672 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
E40MOP2026 |
EnoGene |
20ug |
EUR 495 |
Mouse LIF Protein |
E40MOP2028 |
EnoGene |
20ug |
EUR 495 |
Recombinant Mouse LIF |
Z200195 |
ABM |
10 µg |
EUR 85 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200197 |
ABM |
100 µg |
EUR 385 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200199 |
ABM |
1.0 mg |
EUR 1200 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
Recombinant Mouse LIF |
Z200485 |
ABM |
100 µg |
EUR 1500 |
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix-bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation (2). It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1 (2). The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130. |
anti- LIF antibody |
FNab09804 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against LIF |
Mouse LIF ELISA Kit |
EML0014 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse LIF ELISA Kit |
EK5250 |
SAB |
96 tests |
EUR 599 |
|
Mouse LIF ELISA Kit |
E28L0650 |
EnoGene |
96T |
EUR 666.67 |
Mouse LIF shRNA Plasmid |
20-abx971321 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Mouse LIF Recombinant Protein |
M30-007 |
ReliaTech |
10 µg |
EUR 99.75 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Mouse LIF Recombinant Protein |
M30-008 |
ReliaTech |
50 µg |
EUR 246.75 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. Recombinant mouse LIF produced in E. coli is a single, non-glycosylated, polypeptide chain containing 180 amino acids and having a molecular mass of 19.86 kDa. |
Recombinant Mouse LIF Protein |
R01400-1 |
BosterBio |
100ug/vial |
EUR 352.8 |
Recombinant Mouse LIF Protein |
PKSM041100-100ug |
Elabscience Biotech |
100ug |
EUR 739 |
|
Description: Mouse |
Recombinant Mouse LIF Protein |
PKSM041100-20ug |
Elabscience Biotech |
20ug |
EUR 249 |
|
Description: Mouse |
Mouse LIF PicoKine ELISA Kit |
EK0580 |
BosterBio |
96 wells |
EUR 510 |
Description: For quantitative detection of mouse LIF in cell culture supernates, serum and plasma (heparin, EDTA). |
Anti-Human LIF Antibody |
102-PA05S |
ReliaTech |
100 µg |
EUR 126 |
Description: Leukemia Inhibitory Factor also called LIF is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Human and mouse LIF exhibit a 78% identity in its amino acid sequence. Human LIF is as active on human cells as is it is on mouse cells, though mouse LIF is about 1000 fold less active on human cells, than human LIF. |
Anti-Human LIF Antibody |
101-M553 |
ReliaTech |
100 µg |
EUR 399 |
Description: Based on its helical structure, LIF (Leukemia Inhibitory Factor) is considered a member of the Interleukin-6 family of cytokines. Functionally, it has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. Some cell types known to express LIF include activated T cells, monocytes, astrocytes, osteoblasts, keratinocytes, regenerating skeletal muscle, mast cells, and fibroblasts. |
Lif ORF Vector (Mouse) (pORF) |
ORF049145 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Lif ORF Vector (Mouse) (pORF) |
ORF049146 |
ABM |
1.0 ug DNA |
EUR 607.2 |
LIF, Mouse Recombinant , 1MIU/ml |
L4500-001 |
GenDepot |
1ml |
EUR 406.8 |
LIF, Mouse Recombinant , 1MIU/ml |
L4500-005 |
GenDepot |
5x1ml |
EUR 1431.6 |
LIF ELISA Kit (Mouse) (OKBB00760) |
OKBB00760 |
Aviva Systems Biology |
96 Wells |
EUR 606 |
Description: Description of target: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. The LIF was mapped gene to 22q11-q12.2 by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of 2 normal males and some individuals with chromosomal rearrangements. The gene maps between the Philadelphia translocation BCR1 and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
LIF ELISA Kit (Mouse) (OKEH04045) |
OKEH04045 |
Aviva Systems Biology |
96 Wells |
EUR 652.8 |
Description: Description of target: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL |
LIF, Mouse Recombinant , 10MIU/ml |
L4501-001 |
GenDepot |
1ml |
EUR 1744.8 |
Mouse LIF Recombinant Protein Lyophilized |
IMSLIFRLY5UG |
Innovative research |
each |
EUR 317 |
|
Description: Mouse LIF Recombinant Protein Lyophilized |
Human CellExp? LIF, mouse recombinant |
7268-10 |
Biovision |
each |
EUR 444 |
Mouse LIF protein, C-His tag |
PRP1126-100ug |
Abbkine |
100 μg |
EUR 379 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
PRP1126-1mg |
Abbkine |
1 mg |
EUR 2509 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
PRP1126-20ug |
Abbkine |
20 μg |
EUR 149 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Mouse LIF protein, C-His tag |
PRP1126-5ug |
Abbkine |
5 μg |
EUR 59 |
Description: Mouse LIF protein, C-His tag, expressed in E. coli |
Leukemia Inhibitory Factor (LIF), mouse |
PR16102 |
Neuromics |
5 ug |
EUR 522 |
Leukemia Inhibitory Factor (LIF), mouse |
PR16102-B |
Neuromics |
each |
EUR 436.5 |
Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 1, (10ug) |
MC208887 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (untagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 2, (10ug) |
MC208888 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Recombinant Mouse Lif Protein, No Tag |
E40MOP2217 |
EnoGene |
20ug |
EUR 495 |
Lif (GFP-tagged) - Mouse leukemia inhibitory factor (Lif) transcript variant 2, (10ug) |
MG223901 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (GFP-tagged) - Mouse leukemia inhibitory factor (Lif) transcript variant 1, (10ug) |
MG223120 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (Myc-DDK-tagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 1 |
MR223120 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif (Myc-DDK-tagged) - Mouse leukemia inhibitory factor (Lif), transcript variant 2 |
MR223901 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lif sgRNA CRISPR Lentivector set (Mouse) |
K3872501 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse) |
4-PAA085Mu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF) |
LIF, Leukemia inhibitory factor, murine (mouse) |
RC234-18 |
Bio Basic |
5ug |
EUR 125.26 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-1mg |
Abbexa |
1 mg |
EUR 3801.6 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-3x10g |
Abbexa |
3x10 µg |
EUR 393.6 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-3x2g |
Abbexa |
3x2 µg |
EUR 276 |
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
20-abx067761 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-10mg |
Abbexa |
10 mg |
EUR 325 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-25mg |
Abbexa |
25 mg |
EUR 3287.5 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx262959-5mg |
Abbexa |
5 mg |
EUR 225 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx067761-100g |
Abbexa |
100 µg |
EUR 550 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx067761-10g |
Abbexa |
10 µg |
EUR 212.5 |
Mouse Leukemia Inhibitory Factor (LIF) Protein |
abx067761-50g |
Abbexa |
50 µg |
EUR 387.5 |
Mouse LIF Protein, His Tag (MALS verified) |
LIF-M5227 |
ACROBIOSYSTEMS |
1mg |
EUR 321 |
|
Description: Mouse LIF, His Tag (LIF-M5227) is expressed from human 293 cells (HEK293). It contains AA Ser 24 - Phe 203 (Accession # P09056-1). |
Mouse LIF Protein, Tag Free (MALS verified) |
LIF-M5219 |
ACROBIOSYSTEMS |
20ug |
EUR 2856.9 |
|
Description: Mouse LIF Protein, Tag Free (LIF-M5219) is expressed from human 293 cells (HEK293). It contains AA Ser 24 - Phe 203 (Accession # P09056-1). |
LIF Antibody |
6245-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
LIF Antibody |
6245-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
LIF Antibody |
25283-100ul |
SAB |
100ul |
EUR 468 |
LIF Antibody |
1-CSB-PA012928ESR2HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
LIF Antibody |
E036950 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
LIF Antibody |
F49998-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
LIF Antibody |
F49998-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
LIF Antibody |
E38PA4058 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
LIF Antibody |
E315544 |
EnoGene |
100ug/200ul |
EUR 295 |
Description: Available in various conjugation types. |
LIF Antibody |
E91288 |
EnoGene |
100μg |
EUR 255 |
Description: Available in various conjugation types. |
LIF Antibody |
1-CSB-PA004761 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
LIF Antibody |
36950 |
SAB |
100ul |
EUR 319 |
LIF Antibody |
36950-100ul |
SAB |
100ul |
EUR 302.4 |
LIF Antibody |
5216-100 |
Biovision |
each |
EUR 379.2 |
LIF Antibody |
5216-30T |
Biovision |
each |
EUR 175.2 |
LIF antibody |
70R-14100 |
Fitzgerald |
100 ug |
EUR 519 |
|
Description: Affinity purified Rabbit polyclonal LIF antibody |
LIF antibody |
70R-6230 |
Fitzgerald |
50 ug |
EUR 467 |
|
Description: Rabbit polyclonal LIF antibody |
LIF antibody |
70R-51295 |
Fitzgerald |
100 ul |
EUR 242 |
|
Description: Purified Polyclonal LIF antibody |
LIF antibody |
70R-12299 |
Fitzgerald |
100 ug |
EUR 343 |
|
Description: Rabbit polyclonal LIF antibody |
LIF Antibody |
1-CSB-PA198481 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:10000, IHC:1:25-1:100 |
LIF Antibody |
R30639 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. It is produced in high amounts by the human endometrium and the trophoblast itself, and its receptors are present on cytotrophoblast cells. LIF could thus play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. The gene maps to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. |
LIF Antibody |
R31467 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. This gene is mapped to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF is produced in high amounts by the human endometrium and the trophoblast itself, and LIF receptors are present on cytotrophoblast cells. It could, thus, play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. |
LIF Antibody |
R36251-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
|
Description: Additional name(s) for this target protein: Leukemia inhibitory factor |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
AP75318 |
SAB |
1mg |
EUR 3209 |
|
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-10ug |
Novoprotein |
10ug |
EUR 175.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-1mg |
Novoprotein |
1mg |
EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-500ug |
Novoprotein |
500ug |
EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
C690-50ug |
Novoprotein |
50ug |
EUR 363.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
LIF Protein Vector (Mouse) (pPM-C-HA) |
PV196580 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPM-C-HA) |
PV196584 |
ABM |
500 ng |
EUR 723.6 |
LIF |
E8ER1912-32 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
LIF |
cyt-644 |
ProSpec Tany |
5µg |
EUR 60 |
Description: Recombinant Human Leukemia Inhibitory Factor |
LIF Protein Vector (Mouse) (pPB-C-His) |
PV196578 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPB-N-His) |
PV196579 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPM-C-His) |
PV196581 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPB-C-His) |
PV196582 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPB-N-His) |
PV196583 |
ABM |
500 ng |
EUR 723.6 |
LIF Protein Vector (Mouse) (pPM-C-His) |
PV196585 |
ABM |
500 ng |
EUR 723.6 |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-24Tests |
Elabscience Biotech |
24 Tests |
EUR 180 |
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-48Tests |
Elabscience Biotech |
48 Tests |
EUR 546 |
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-96Tests |
Elabscience Biotech |
96 Tests |
EUR 682 |
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-96Tests10 |
Elabscience Biotech |
96 Tests *10 |
EUR 6820 |
|
Description: Sandwich |
Mouse LIF -Leukemia Inhibitory Factor- CLIA Kit |
E-CL-M0038-96Tests5 |
Elabscience Biotech |
96 Tests *5 |
EUR 3410 |
|
Description: Sandwich |
Anti-Human LIF R alpha Antibody |
101-M554 |
ReliaTech |
100 µg |
EUR 399 |
Description: The activities of the pleiotropic cytokine LIF are mediated through a high-affinity heterodimeric receptor complex consisting of two membrane glycoproteins: an alpha subunit (LIF R alpha, also known as LIF R beta and CD118) that binds LIF with low affinity and the 130 kDa (gp130) subunit that does not bind LIF by itself, but is required for high-affinity binding of LIF by the complex. |
Mouse Lif/ Leukemia inhibitory factor ELISA Kit |
E1656Mo |
Sunlong |
1 Kit |
EUR 543 |
|
Description: Differentiation-stimulating factor,D factor |
Mouse Lif(Leukemia inhibitory factor) ELISA Kit |
EM0237 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 46.9pg/ml |
Mouse Lif / Leukemia inhibitory factor ELISA Kit |
E0085m |
EIAab |
96T |
EUR 776 |
anti-LIF |
YF-PA12952 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to LIF |
Mouse LIF Protein (Ser 24-Phe 203) [His] |
VAng-1946Lsx-20g |
Creative Biolabs |
20 µg |
EUR 588 |
Description: Mouse LIF protein, His tag, expressed in human 293 cells. (Uniprot ID: P09056) |
Mouse LIF Protein (Ser 24-Phe 203) [His] |
VAng-1946Lsx-50g |
Creative Biolabs |
50 µg |
EUR 1050 |
Description: Mouse LIF protein, His tag, expressed in human 293 cells. (Uniprot ID: P09056) |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), PE |
4-PAA085Mu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with PE. |
Recombinant Mouse LIF Protein, Untagged, E.coli-1mg |
QP4235-1mg |
EnQuireBio |
1mg |
EUR 3189.6 |
Recombinant Mouse LIF Protein, Untagged, E.coli-5ug |
QP4235-5ug |
EnQuireBio |
5ug |
EUR 163.2 |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), APC |
4-PAA085Mu01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with APC. |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), Cy3 |
4-PAA085Mu01-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with Cy3. |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), HRP |
4-PAA085Mu01-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with HRP. |
Mouse LIF Recombinant Protein Tag Free Lyophilized |
IMSLIFRTFLY50UG |
Innovative research |
each |
EUR 681 |
|
Description: Mouse LIF Recombinant Protein Tag Free Lyophilized |
Recombinant Mouse LIF Protein, Untagged, E.coli-20ug |
QP4235-20ug |
EnQuireBio |
20ug |
EUR 284.4 |
Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), FITC |
4-PAA085Mu01-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with FITC. |
Recombinant Mouse LIF Protein, Untagged, E.coli-100ug |
QP4235-100ug |
EnQuireBio |
100ug |
EUR 729.6 |
Recombinant Mouse LIF Protein, Untagged, E.coli-500ug |
QP4235-500ug |
EnQuireBio |
500ug |
EUR 1992 |
Lif sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3872502 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Lif sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3872503 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Comparisons point out a excessive degree of settlement in responses throughout the protocols and tradition circumstances. The total correlation in outcomes was 0.88 between the usual and small quantity protocols, and 0.86 between the usual and capillary blood protocols. Repeatability for the small quantity and capillary blood protocols was excessive, with imply coefficient of variation throughout 5 replicates of 6.2 and 5.4%, respectively.ConclusionsThese outcomes reveal the feasibility of culturing cells and quantifying the inflammatory response to problem outdoors the lab, with a wide selection of potential functions in biobehavioral analysis in community-based and distant subject settings.